LNAnteFRA:2N3 +0.31%84 FCF Margin % is 11.46% as of Dec. 2025, which is 2% above its 10-year median of 11.23. GuruFocus rates FRA:2N3 with a GF Score™ of 84/100 and a GF Value™ of €28.88 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 669 Healthcare Providers & Services companies, LNAnte ranks better than 70.85% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. LNAnte's Free Cash Flow for the
six
months ended in Dec. 2025 was €53.4 Mil. LNAnte's Revenue for the
six
months ended in Dec. 2025 was €466.2 Mil. Therefore, LNAnte's FCF Margin % for the quarter that ended in Dec. 2025 was 11.46%.
The historical rank and industry rank for LNAnte's FCF Margin % or its related term are showing as below:
FRA:2N3'
s FCF Margin % Range Over the Past 10 Years
Min: 4.79 Med: 11.23 Max: 23.13
Current: 9.46
During the past 13 years, the highest FCF Margin % of LNAnte was 23.13%. The lowest was 4.79%. And the median was 11.23%.
FRA:2N3's FCF Margin % is ranked better than 70.85% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.39
vs FRA:2N3: 9.46
LNAnte FCF Margin % Related Terms
LNAnte FCF Margin % Historical Data
* Premium members only.
The historical data trend for LNAnte's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, LNAnte's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LNAnte FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LNAnte's FCF Margin % distribution charts can be found below:
* The bar in red indicates where LNAnte's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LNAnte (FRA:2N3) has a FCF Margin % of 11.46% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on LNAnte and its competitors. This is near median its historical median of 11.23. Over the past decade, LNAnte's FCF Margin % has ranged from 4.79 to 23.13. According to the industry distribution chart, LNAnte ranks #195 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 29.1%.
Is LNAnte's FCF Margin % too high?
LNAnte's current FCF Margin % of 11.46% is near median its 10-year median of 11.23. Over the past 10 years, this metric has ranged from a low of 4.79 to a high of 23.13. The Healthcare Providers & Services industry median FCF Margin % is 3.39. LNAnte's value of 11.46% is 238.1% above this industry median. Based on the distribution chart, LNAnte ranks #195 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LNAnte has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LNAnte's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, LNAnte ranks #195 out of 669 companies for FCF Margin %. This puts LNAnte in the upper half of its industry. The industry median FCF Margin % is 3.39. LNAnte's value of 11.46% is 238.1% above this benchmark. Historically, LNAnte's own FCF Margin % has ranged from 4.79 to 23.13 over the past decade. While the company's 10-year median is 11.23 vs. the industry median of 3.39, LNAnte has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LNAnte's current FCF Margin % of 11.46% is 238.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on LNAnte and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LNAnte's current FCF Margin % is 11.46%, which is near median its own 10-year median of 11.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LNAnte stock overvalued right now?
Based on GuruFocus' analysis, LNAnte (FRA:2N3) is currently considered Modestly Overvalued. The stock's GF Value™ is €28.88, compared to a current price of €32.30 — trading 11.8% above its estimated fair value. The current FCF Margin % is 11.46%, which is near median its 10-year median of 11.23 and 238.1% above the Healthcare Providers & Services industry median of 3.39. LNAnte's overall GF Score™ is 84/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For LNAnte (FRA:2N3), the current FCF Margin % is 11.46% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LNAnte (FRA:2N3) Overvalued in 2026?
Based on GuruFocus' analysis, LNAnte stock appears to be overvalued.
The current stock price of €32.30 is trading 11.8% above its estimated GF Value™ of €28.88.
GuruFocus considers LNAnte to be Modestly Overvalued.
Key valuation signals for FRA:2N3:
FCF Margin %: 11.46% (near median its 10-year median of 11.23)
GF Value™: €28.88 vs. price of €32.30 (11.8% above fair value)
Industry Position: 238.1% above the Healthcare Providers & Services median (#195 of 669)
No single metric tells the full story. See the FRA:2N3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LNA Sante SA is engaged in the management and operation of retirement homes, nursing homes, follow-up care clinics, rehabilitation centers, centers for the disabled and handicapped ageing.
84GF Score
Get the complete analysis for FRA:2N3
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2N3 has been successfully added to your 
